Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein
Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic protein Scios Inc, Brown University, Amgen Clinical Immunology (2007). [ISPRI prediction of immunogenicity]
Epitope-Driven TB Vaccine Development: A streamlined approach using immunoinformatics, ELISpot assays, and HLA transgenic mice
Current Molecular Medicine, Curr Mol Med. 2007 Jun;7(4):351-68.
Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: Identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine
Vaccine. 2007 Apr 20;25(16):3179-91.